Citigroup has lowered Adobe’s price target from $551 to $490, maintaining a neutral rating. Other analysts have also reduced ...

CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...

(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, ...

Eli Lilly plans to globally launch its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

Stifel Nicolaus analyst J. Parker Lane maintained a Buy rating on Adobe (ADBE – Research Report) today and set a price target of $600.00. The ...

In a report released today, Tyler Radke from Citi maintained a Hold rating on Adobe (ADBE – Research Report), with a price target of $490.00.

On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...

Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier.

Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...